Related Experiment Videos

The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation

Insights

Multidrug resistance in cancer cells stems from the mdr1 gene. This gene

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Multidrug resistance (MDR) is a significant challenge in cancer chemotherapy.
  • Overexpression and amplification of the multidrug resistance gene (mdr1) are key mechanisms in MDR.
  • KB carcinoma cells selected for resistance to colchicine, vinblastine, or adriamycin exhibit MDR.

Purpose of the Study:

  • To characterize the mdr1 gene transcript and its expression in multidrug-resistant human cells.
  • To investigate the transcriptional start sites and gene structure of mdr1.
  • To understand the genetic basis of multidrug resistance in human KB carcinoma cells.

Main Methods:

  • Obtained overlapping cDNA clones for the 4.7-kilobase mdr1 transcript.
  • Utilized primer extension and S1 nuclease protection assays to determine transcript initiation sites.
  • Performed Southern hybridization analyses to assess mdr1 gene amplification and size.

Main Results:

  • Identified two primary mdr1 transcripts initiating 136 and 140 bases upstream of the ATG codon in all MDR cell lines.
  • Confirmed mdr1 gene expression in normal human kidney and HepG2 liver cells from the same start sites.
  • Detected less prominent transcripts with alternative start sites in specific drug-selected cell lines.
  • Southern analysis indicated the human mdr1 gene spans at least 70 kilobases and is amplified in MDR cells.

Conclusions:

  • The mdr1 gene is amplified and overexpressed in multidrug-resistant human KB carcinoma cells.
  • Specific transcriptional start sites for mdr1 are conserved across different MDR cell lines and also present in normal cells.
  • Alternative transcription initiation contributes to the complex expression patterns of mdr1 in response to different chemotherapeutic agents.

Related Concept Videos